Finance

Lists
HIK:LON
Hikma Pharmaceuticals Plc
GBX 1,677.00
-1.29%
(-22.00) 1D
Aug 7, 4:53:17 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for HIK...
Open
GBX 1,703.00
High
GBX 1,723.00
Low
GBX 1,671.00
Mkt. cap
3.52B
Avg. vol.
1.11M
Volume
910.84K
Dividend
3.79%
Quarterly dividend
GBX 15.89
Ex-dividend date
Mar 19, 2026
P/E ratio
12.86
52-wk high
GBX 1,865.00
52-wk low
GBX 1,187.00
EPS
GBX 1.30
Shares outstanding
210.14M
No. of employees
9K
Open
GBX 1,703.00
High
GBX 1,723.00
Low
GBX 1,671.00
Mkt. cap
3.52B
Avg. vol.
1.11M
Volume
910.84K
Dividend
3.79%
Quarterly dividend
GBX 15.89
Ex-dividend date
Mar 19, 2026
P/E ratio
12.86
52-wk high
GBX 1,865.00
52-wk low
GBX 1,187.00
EPS
GBX 1.30
Shares outstanding
210.14M
No. of employees
9K
News stories
From sources across the web
About Hikma Pharmaceuticals Plc
CEO-
Employees9.4K
Founded1978
HeadquartersLondon, England, United Kingdom
SectorPharmaceutical industry
Websitehikma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
845.50M
845.50M
864.00M
864.00M
Cost of goods sold
479.50M
479.50M
477.00M
477.00M
Cost of revenue
479.50M
479.50M
477.00M
477.00M
Research and development expenses
39.00M
39.00M
43.00M
43.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
194.00M
194.00M
141.00M
141.00M
Operating expense
229.00M
229.00M
184.00M
184.00M
Total operating expenses
708.50M
708.50M
661.00M
661.00M
Operating income
137.00M
137.00M
203.00M
203.00M
Other non operating income
-6.00M
-6.00M
-
-
EBT including unusual items
112.00M
112.00M
143.50M
143.50M
EBT excluding unusual items
104.00M
104.00M
178.50M
178.50M
Income tax expense
28.50M
28.50M
31.00M
31.00M
Effective tax rate
25.45%
25.45%
21.60%
21.60%
Other operating expenses
-4.00M
-4.00M
-
-
Net income
82.00M
82.00M
111.50M
111.50M
Net profit margin
9.70%
9.70%
12.90%
12.90%
Earnings per share
-
-
-
-
Interest and investment income
1.00M
1.00M
1.50M
1.50M
Interest expense
-22.50M
-22.50M
-26.00M
-26.00M
Net interest expenses
-21.50M
-21.50M
-24.50M
-24.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
183.00M
183.00M
250.50M
250.50M
Gain or loss from assets sale
500.00K
500.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps